MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Henry Schein Q1 profits increase 26 percent after healthy sales bump
Henry Schein Inc. (NSDQ:HSIC) posted profits of $76.5 million, or 82 cents per diluted share, on sales of $1.95 billion during the three months ended March 26. That compares with profits of $60.9 million, or 66 cents per diluted share, on sales of $1.76 billion during the same period last year.
Read more
Solta Medical losses ease
Solta Medical Inc. (NYSE:SLTM) reported a loss of $1.0 million, or 2 cents per diluted share, on revenue of $26.5 million during the three months ended March 31. That compares with a loss of $1.9 million, or 3 cents per diluted share, on revenue of $25.9 million during the same period last year.
Read more
Thoratec’s 23 percent profit increase defies flat sales
Thoratec Corp. (NSDQ:THOR) posted profit of $16.5 million, or 27 cents per diluted share, on sales of $99.5 million during the three months ended April 2. That compares with profits of $13.4 million, or 23 cents per diluted share, on sales of $99.3 million during the same period last year.
Read more
Masimo profits fall despite sales rise
Masimo Corp. (NSDQ:MASI) posted profits of $18.0 million, or 30 cents per diluted share, on sales of $113.0 million during the three months ended April 2. That compares with profits of $26.7 million, or 44 cents per diluted share, on sales of $98.8 million during the same period last year.
Read more
American Medical Systems sales, profits see modest gains
American Medical Systems Holdings Inc. (NSDQ:AMMD) posted net earnings of $21.6 million, or 27 cents per diluted share, on revenue of $140.8 million during the three months ended April 2. That compares with net earnings of $20.7 million, or 27 cents per diluted share, on revenue of $134.9 million during the same period last year.
Read more
Exactech profits shrink despite sales rise
Exactech Inc. (NSDQ:EXAC) posted net earnings of $3.0 million, or 22 cents per diluted share, on revenue of $53.4 million during the three months ended March 31. That compares with profits of $3.3 million, or 26 cents per diluted share, on revenue of $49.1 million during the same period last year.
Read more
CardioNet losses ease after modest revene increase
CardioNet Inc. (NSDQ:BEAT) reported a loss of $1.6 million, or 6 cents per diluted share, on sales of $34.0 million during the three months ended March 31. That compares with a loss of $5.4 million, or 23 cents per diluted share, on sales of $31.8 million during the same period last year.
McKesson Q4 profits jump 21 percent to $422 million
McKesson Corp. (NYSE:MCK) posted profits of $422 million, or $1.62 per diluted share, on sales of $28.9 billion during the three months ended March 31. That compares with profits of $348 million, or $1.26 per diluted share, on sales of $26.6 billion during the same period last year.
Full-year profits were $1.20 billion, or $4.57 per diluted share, on sales of $112.08 billion. That compares with profits of $1.26 million, or $4.62 per diluted share, on sales of $108.70 billion for fiscal year 2010.
Read more
Charles River Labs profits leap despite revenue slump
Charles River Laboratories International Inc. (NYSE:CRL) posted net earnings of $31.3 million, or 57 cents per diluted share, on revenue of $285.8 million during the three months ended March 26. That compares with net earnings of $17.4 million, or 26 cents per diluted share, on revenue of $292.3 million during the same period last year.
Read more
DexCom losses ease after revenues double
DexCom Inc. (NSDQ:DXCM) reported a loss of $11.9 million, or 19 cents per diluted share, on revenue of $13.1 million during the three months ended March 31. That compares with a loss of $20.3 million, or 40 cents per diluted share, on revenue of $6.8 million during the same period last year.
Read more
STAAR Surgical profits almost disapear despite modest sales increase
STAAR Surgical Co. (NSDQ:STAA) reported profits of $300,000, or 1 cent per diluted share, on revenue of $14.8 million during the three months ended April 1. That compares with profits of $3.5 million, or 10 cents per diluted share, on revenue of $13.8 million during the same period last year.
Read more
IntriCon dips into the red
IntriCon Corp. (NYSE:IIN) posted a loss of $290,000, or 5 cents per diluted share, on sales of $13.8 million during the three months ended March 31. That compares with a profit of $18,000, or 0 cents per diluted share, on sales of $14.6 million during the same period last year.
Read more
Genomic Health losses ease after 23 percent jump in sales
Genomic Health Inc. (NSDQ:GHDX) reported a loss of $286,000, or 1 cent per diluted share, on revenue of $49.5 million during the three months ended March 31. That compares with losses of $1.9 million, or 7 cents per diluted share, on revenue of $40.3 million during the same period last year.
Read more
Cynosure losses ease on revenue rise
Cynosure Inc. (NSDQ:CYNO) posted a loss of $1.9 million, or 15 cents per diluted share, on sales of $21.9 million during the three months ended March 31. That compares with a loss of $2.8 million, or 22 cents per diluted share, on sales of $18.9 million during the same period last year.
Read more
